Sponsor pipeline

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical trial pipeline

Get alerts when National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

Show 2 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 2
20
Phase 2/3
1
Phase 3
1
Phase 4
1
Not charted: 38 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 16

Diabetes (18) · Obesity (13) · Head & Neck Cancer (7) · Heart Disease (6) · Thyroid Cancer (5) · Type 1 Diabetes (5) · NASH / MASH (3) · Chronic Kidney Disease (2) · Hypertension (2) · Type 2 Diabetes (2)

Get alerts when National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free